In conclusion, our findings suggest that inhibition of PRMT1 mitigates SI‐AKI by inactivating the TGF‐β1/Smad3 pathway in the cortex and the IL‐6/STAT3 pathway in the medulla. This evidence concerns the gene SMAD3 and acute kidney injury.